Major Scope
- Cardiovascular Case Reports
- Oncology Case Reports
- Surgical Case Reports
- Gastroenterological Case Reports
- Neurological Case Reports
- Dermatological Case Reports
- Respiratory Case Reports
- Obstetrics/Gynecology Case Reports
- Nephrology Case Reports
- Immunology Case Reports
- Paediatric Case Reports
- Orthopedics Case Reports
- Dental Case Reports
Abstract
Citation: Clin Case Rep Int. 2020;4(1):1147.DOI: 10.25107/2638-4558.1147
A Patient with BRAFV600E - Mutant Lung Adenocarcinoma Responding to Dabrafenib and Trametinib
Chloé Denis and Frédérique Bustin
Department of Oncology, University of Liège Hospital, Belgium Department of Pneumology, CHR de la Citadelle, Belgium
*Correspondance to: Chloé Denis
PDF Full Text Case Report | Open Access
Abstract:
BRAF is a gene that encodes a protein belonging to the RAF family of protein kinases. This protein transduces signals via the mitogen-activated protein kinase pathway to the nucleus of receptive cells. We report another case of BRAFV600E-mutant lung adenocarcinoma responding to dabrafenib and trametinib treatment.
Keywords:
Cite the Article:
Denis C, Bustin F. A Patient with BRAFV600E - Mutant Lung Adenocarcinoma Responding to Dabrafenib and Trametinib. Clin Case Rep Int. 2020; 4: 1147.
Journal Basic Info
- Impact Factor: 4.082**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Search Our Journal
Journal Indexed In
